The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 162-167

  Andersson, Bert ^a,c   Sylvén, Christer ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Sahlgrenska Sjukhuset   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; HEART LEFT VENTRICLE MASS; HOMOZYGOSITY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SWEDEN;

EID: 0030198578     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00098-8     Document Type: Article

References (40)

1. 1. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-23.
2. 2. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure -relations to survival and the effects of therapy in V-Heft-II. Circulation 1993;87 Suppl 6:40-8.
3. 3. Swedberg K, Eneroth P, Kjekshus D, Snapinn S, for the CONSENSUS trial study group. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). Am J Cardiol 1990;66:40D-5D.
4. 4. Lonn EM, Yusuf S, Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994;90: 2056-69.
5. 5. Haber HL, Powers ER, Gimple LW, et al. Intracoronary angiotensin-converting enzyme inhibition improves diastolic function in patients with hypertensive left ventricular hypertrophy. Circulation 1994;89:2616-25.
6. 6. Linz W, Scholkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989;11:1325-50.
7. 7. Wollert KC, Studer R, von Bülow B, Drexler H. Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition. Circulation 1994;90:2457-67.
8. 8. Dzau VJ, Pratt R, Gibbons GH. Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease. Drugs 1994;47 Suppl 4:1-13.
9. 9. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35.
10. 10. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
11. 11. Hubert C, Houot A-M, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991;266:15377-83.
12. 12. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
13. 13. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
14. 14. Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am J Hum Genet 1988;43:774-80.
15. 15. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
16. 16. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
17. 17. Raynolds MV, Bristow MR, Bush EW, et al. Angiotensin-converting enzyme-DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993;342:1073-5.
18. 18. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994;330:1634-8.
19. 19. Hegele RA, Brunt JH, Connelly PW. A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994;90:2207-12.
20. 20. Soubrier F, Nadaud S, Williams TA. Angiotensin I converting enzyme gene: regulation, polymorphism and implications in cardiovascular diseases. Eur Heart J 1994;15 Suppl D:24-9.
21. 21. Lachurié M-L, Azizi M, Guyene T-T, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995;91:2933-42.
22. 22. Mattu RK, Needham EWA, Gallon DJ, Frangos E, Clark AJL, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995;91:270-4.
23. 23. Andersson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J 1993;126:632-40.
24. 24. Andersson B, Caidahl K, Waagstein F. An echocardiographic evaluation of patients with idiopathic heart failure. Chest 1995;107:680-9.
25. 25. Andersson B, Caidahl K, Waagstein F. Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J 1995;16: 53-60.
26. 26. Rose EA, Blackburn H. Cardiovascular survey methods: WHO monograph series No. 56. Geneva: World Health Organization, 1982:123-42.
27. 27. Sahn DJ, DeMaria A, Kisslo J, Weyraan A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
28. 28. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy, Am J Cardiol 1976;37:7-11.
29. 29. Caidahl K, Eriksson H, Hartford M, et al. Dyspnoea of cardiac origin in 67 year old men: (2) relation to diastolic left ventricular function and mass. The study of men born in 1913. Br Heart J 1988;59:329-38.
30. 30. Rigat B, Hubert C, Alhenc-Gelas F, Roeckel N, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res 1992;20:1433.
31. 31. Pinto YM, van Gilst WH, Kingma JH, Schunkert H, for the Captopril and Thrombolysis Study Investigators. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after anterior myocardial infarction. J Am Coll Cardiol 1995;25:1622-6.
32. 32. Sun Y, Ratajska A, Zhou GP, Weber KT. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin-ii or aldosterone. J Lab Clin Med 1993;122:395-403.
33. 33. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970-5.
34. 34. Weinberg EO, Schoen FJ, George D, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994;90:1410-22.
35. 35. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
36. 36. Lièvre M, Guéret P, Gayet C, et al, on behalf of the HYCAR Study Group. Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. Hypertension 1995;25:92-7.
37. 37. Johnston CI, Mooser V, Sun Y, Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol 1990;18:107-10.
38. 38. Carlsson L, Abrahamsson T. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium. Eur J Pharmacol 1989;166:157-64.
39. 39. Lechin M, Quiñones MA, Omran A, et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995;92:1808-12.
40. 40. Lindpaintner K, Pfeffer MA. Molecular genetics crying wolf? The case of the angiotensin-converting enzyme gene and cardiovascular disease. J Am Coll Cardiol 1995;25:1632-3.